Damien Bolton
Damien Bolton
Verified email at
Cited by
Cited by
Sensitivity, specificity, and predictors of positive 68Ga–prostate-specific membrane antigen positron emission tomography in advanced prostate cancer: a systematic review and …
M Perera, N Papa, D Christidis, D Wetherell, MS Hofman, DG Murphy, ...
European urology 70 (6), 926-937, 2016
Gallium-68 prostate-specific membrane antigen positron emission tomography in advanced prostate cancer—updated diagnostic utility, sensitivity, specificity, and distribution …
M Perera, N Papa, M Roberts, M Williams, C Udovicich, I Vela, ...
European urology 77 (4), 403-417, 2020
Laser ablation of the prostate in patients with benign prostatic hypertrophy
AJ Costello, WG Bowsher, DM Bolton, KG Braslis, J Burt
British journal of urology 69 (6), 603-608, 1992
Re: Five Year Results of the Prospective Randomized Controlled Prostatic Urethral LIFT Study
SA Kaplan
Journal of Urology 200 (5), 920-921, 2018
Clinical role of F-18 fluorodeoxyglucose positron emission tomography for detection and management of renal cell carcinoma
S RAMDAVE, GW THOMAS, SU Berlangieri, DM Bolton, IAN DAVIS, ...
The Journal of urology 166 (3), 825-830, 2001
The prostatic urethral lift for the treatment of lower urinary tract symptoms associated with prostate enlargement due to benign prostatic hyperplasia: the LIFT Study
CG Roehrborn, SN Gange, ND Shore, JL Giddens, DM Bolton, BE Cowan, ...
The Journal of urology 190 (6), 2161-2167, 2013
Germline BRCA2 mutations drive prostate cancers with distinct evolutionary trajectories
RA Taylor, M Fraser, J Livingstone, SMG Espiritu, H Thorne, V Huang, ...
Nature communications 8 (1), 13671, 2017
Increase in visceral and subcutaneous abdominal fat in men with prostate cancer treated with androgen deprivation therapy
EJ Hamilton, E Gianatti, BJ Strauss, J Wentworth, D Lim‐Joon, D Bolton, ...
Clinical endocrinology 74 (3), 377-383, 2011
Nd: YAG laser ablation of the prostate as a treatment for benign prostatic hypertrophy
AJ Costello, DE Johnson, DM Bolton
Lasers in surgery and medicine 12 (2), 121-124, 1992
68Ga-prostate specific membrane antigen (PSMA) positron emission tomography (PET) for primary staging of high-risk prostate cancer: a systematic review
J Corfield, M Perera, D Bolton, N Lawrentschuk
World journal of urology 36, 519-527, 2018
Prostatic urethral lift: two-year results after treatment for lower urinary tract symptoms secondary to benign prostatic hyperplasia
PT Chin, DM Bolton, G Jack, P Rashid, J Thavaseelan, RJ Yu, ...
Urology 79 (1), 5-11, 2012
The CROES percutaneous nephrolithotomy global study: the influence of body mass index on outcome
A Fuller, H Razvi, JD Denstedt, L Nott, M Pearle, F Cauda, D Bolton, ...
The Journal of urology 188 (1), 138-144, 2012
Patient-derived xenografts reveal that intraductal carcinoma of the prostate is a prominent pathology in BRCA2 mutation carriers with prostate cancer and correlates with poor …
GP Risbridger, RA Taylor, D Clouston, A Sliwinski, H Thorne, S Hunter, ...
European Urology 67 (3), 496-503, 2015
Indirect comparisons of efficacy between combination approaches in metastatic hormone-sensitive prostate cancer: a systematic review and network meta-analysis
NJ Sathianathen, S Koschel, IA Thangasamy, J Teh, O Alghazo, ...
European urology 77 (3), 365-372, 2020
Three year results of the prostatic urethral LIFT study.
CG Roehrborn, DB Rukstalis, J Barkin, SN Gange, ND Shore, JL Giddens, ...
The Canadian journal of urology 22 (3), 7772-7782, 2015
Minimally invasive prostatic urethral lift: surgical technique and multinational experience
TA McNicholas, HH Woo, PT Chin, D Bolton, MF Arjona, KD Sievert, ...
European urology 64 (2), 292-299, 2013
Assessing regional hypoxia in human renal tumours using 18F‐fluoromisonidazole positron emission tomography
N Lawrentschuk, AMT Poon, SS Foo, LGJ Putra, C Murone, ID Davis, ...
BJU international 96 (4), 540-546, 2005
Multidetector computed tomography vs magnetic resonance imaging for defining the upper limit of tumour thrombus in renal cell carcinoma: a study and review
N Lawrentschuk, J Gani, R Riordan, S Esler, DM Bolton
BJU international 96 (3), 291-295, 2005
Is fosfomycin a potential treatment alternative for multidrug-resistant gram-negative prostatitis?
BJ Gardiner, AA Mahony, AG Ellis, N Lawrentschuk, DM Bolton, ...
Clinical Infectious Diseases 58 (4), e101-e105, 2014
Decreased Prostate Cancer-Specific Survival of Men with BRCA2 Mutations from Multiple Breast Cancer Families
H Thorne, AJ Willems, E Niedermayr, IMY Hoh, J Li, D Clouston, ...
Cancer Prevention Research 4 (7), 1002-1010, 2011
The system can't perform the operation now. Try again later.
Articles 1–20